Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease.Annals of Neurology; https://doi.org/10.1002/ana.25557.
Functionalization of the TMEM175 p.M393T Variant as a risk factor for Parkinson Disease..Hum Mol Genet.; DOI: 10.1093/hmg/ddz136.
TREM2 deficiency aggravates α-synuclein–induced neurodegeneration and neuroinflammation in Parkinson’s disease models..FASEB J.; DOI: 10.1096/fj.201900992R.
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model..Alzheimers Dement.; doi: 10.1016/j.jalz.2019.02.002.
α-synuclein promotes progression of Parkinson's disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome.Spandidos Publications; https://doi.org/10.3892/etm.2019.8297.
Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease.Food & Function; DOI: 10.1039/c8fo00964c.